Novel Carbon Quantum Dots Precisely Trigger Ferroptosis in Cancer Cells through Antioxidant Inhibition Synergistic Nanocatalytic Activity
ACS Applied Materials & Interfaces · 2024-07-24 · 16 (29) · 37456-37467
DOI: 10.1021/acsami.4c04307 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published on 2024-07-24. Written by Nianqiang Jin and 9 co-authors. Institution: Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, People's Republic of China. Major MEDLINE topics: Ferroptosis, Quantum Dots, Carbon, Glutathione. Cited 13 times so far (Crossref); 48 references. Funded by: Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation, Southern Medical University.
Abstract (original language)
High levels of glutathione (GSH) are an important characteristic of malignant tumors and a significant cause of ineffective treatment and multidrug resistance. Although reactive oxygen species (ROS) therapy has been shown to induce tumor cell death, the strong clearance effect of GSH on ROS significantly reduces its therapeutic efficacy. Therefore, there is a need to develop new strategies for targeting GSH. In this study, novel carbon quantum dots derived from gentamycin (GM-CQDs) were designed and synthesized. On the basis of the results obtained, GM-CQDs contain sp2 and sp3 carbon atoms as well as nitrogen oxygen groups, which decrease the intracellular levels of GSH by downregulating SLC7A11, thereby disrupting redox balance, mediating lipid peroxidation, and inducing ferroptosis. Transcriptome analysis demonstrated that GM-CQDs downregulated the expression of molecules related to GSH metabolism while significantly increasing the expression of molecules related to ferroptosis. The in vivo results showed that the GM-CQDs exhibited excellent antitumor activity and immune activation ability. Furthermore, because of their ideal biological safety, GM-CQDs are highly promising for application as drugs targeting GSH in the treatment of malignant tumors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, People's Republic of China.
- School and Hospital of Stomatology, China Medical University, Shenyang, Liaoning 110002, People's Republic of China.
- Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, People's Republic of China.
- Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, Liaoning 110002, People's Republic of China.
- School and Hospital of Stomatology, Jilin University, Changchun, Jilin 130000, People's Republic of China.
- Department of Tissue Engineering, Center of 3D Printing & Organ Manufacturing, School of Fundamental Sciences, China Medical University, Shenyang, Liaoning 110001, People's Republic of China.
ORCID profiles: Longquan Shao
Funding
- Basic and Applied Basic Research Foundation of Guangdong Province
- China Postdoctoral Science Foundation
- Southern Medical University
- National Natural Science Foundation of China
- Guangdong Medical Research Foundation
Cite
APA
Jin, N., Wang, Z., Yin, C., Bu, W., Jin, N., Ou, L., Xie, W., He, J., Lai, X., & Shao, L. (2024). Novel Carbon Quantum Dots Precisely Trigger Ferroptosis in Cancer Cells through Antioxidant Inhibition Synergistic Nanocatalytic Activity. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c04307
Vancouver
Jin N, Wang Z, Yin C, Bu W, Jin N, Ou L, et al. Novel Carbon Quantum Dots Precisely Trigger Ferroptosis in Cancer Cells through Antioxidant Inhibition Synergistic Nanocatalytic Activity. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c04307
BibTeX
@article{Jin2024,
author = {Jin, Nianqiang and Wang, Zilin and Yin, Chengcheng and Bu, Wenhuan and Jin, Nuo and Ou, Lingling and Xie, Wenqiang and He, Jiankang and Lai, Xuan and Shao, Longquan},
title = {Novel Carbon Quantum Dots Precisely Trigger Ferroptosis in Cancer Cells through Antioxidant Inhibition Synergistic Nanocatalytic Activity},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c04307}
}
EUVIMED